About me
Vik Chawla has over 14 years of experience advising leading biopharma companies on a wide range of strategic issues, including portfolio strategy, M&A, commercial due diligence, forecasting, and commercialization. In addition, Vik led and supported numerous commercial due diligence and product launch efforts, spanning oncology, rare diseases, and cell and gene therapies.
Before joining Syneos Health, Vik worked in the Deals Strategy and Transactions group at PwC Strategy&. His prior experience also includes providing strategy consulting services at LEK consulting and IQVIA. He also worked at Oncology Global commercial business unit at Pfizer.
Vik earned his MBA from the University of Maryland and BS in Mechanical from PEC, India.
